| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/22/2011 | CA2471769C Oral insulin therapy |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
| 03/22/2011 | CA2433675C Pharmaceutically active piperidine derivatives |
| 03/17/2011 | WO2011030929A1 Compound for inhibiting type 3 17β-hydroxysteroid dehydrogenase |
| 03/17/2011 | WO2011030927A1 Compound for inhibiting type-3 17β-hydroxysteroid dehydrogenase |
| 03/17/2011 | WO2011029633A1 Heterocyclic mglu5 antagonists |
| 03/17/2011 | WO2011029392A1 Androgen receptor antagonists and uses thereof |
| 03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
| 03/17/2011 | US20110065778 RNA Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 03/17/2011 | US20110065764 5- phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065746 Composition of solifenacin or salt thereof for use in solid formulation |
| 03/17/2011 | US20110065720 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
| 03/17/2011 | US20110065681 Amide compounds, compositions and uses thereof |
| 03/17/2011 | US20110065643 Clusterin Pharmaceuticals and Treatment Methods Using the Same |
| 03/17/2011 | US20110065627 Transdermal delivery of medicaments with combinations of cetylated fatty fatty ester penetrant complexes |
| 03/17/2011 | US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases |
| 03/17/2011 | US20110064820 Pharmaceutical Compositions Comprising Phosphate-Binding Polymer |
| 03/17/2011 | US20110064774 Bulking agent |
| 03/17/2011 | US20110064757 Nucleic acid molecules and polypeptides for immune modulation |
| 03/17/2011 | US20110064706 Method of preventing, controlling and ameliorating urinary tract infections and supporting digestive health by using a synergistic cranberry derivative, a d-mannose composition and a proprietary probiotic blend |
| 03/17/2011 | US20110064689 In situ immunization |
| 03/17/2011 | CA2772579A1 Thioimidazolidinone androgen receptor antagonists and uses thereof |
| 03/16/2011 | EP2295606A1 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 03/16/2011 | EP2295529A2 Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295436A1 2-Phenyl-subsitituted Imidazotriazinones as Phosphodiesterase V inhibitors |
| 03/16/2011 | EP2295415A1 Quinazoline derivatives |
| 03/16/2011 | EP2295063A2 Compositions and the use thereof the treatment of mitochondrial diseases |
| 03/16/2011 | EP2295053A1 Novel 2H-chromen-2-one-3-carboxamides for medical uses |
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2294047A2 Novel mandelate salt of fesoterodine |
| 03/16/2011 | EP1704140B1 Synthesis of optically pure (r)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide |
| 03/16/2011 | EP1495018B3 Tricyclic thrombin receptor antagonists |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | EP1344777B1 Imidazole derivatives, process for their preparation and their use |
| 03/16/2011 | CN101986782A Substituted heteroarylamide diazepinopyrimidone derivatives |
| 03/16/2011 | CN101985457A Medicinal salts of cordycepin and preparation method and medicinal application thereof |
| 03/16/2011 | CN101985018A Chinese herbal medicine for treating enuresis of children |
| 03/16/2011 | CN101985003A Medicinal liquor with effects of tonifying kidney and holding qi |
| 03/16/2011 | CN101984990A Traditional Chinese medicinal composition for treating postpartum frequent urine |
| 03/16/2011 | CN101984988A Powder for treating white secretion flow disease |
| 03/16/2011 | CN101984975A Medical composition containing cordycepin derivatives |
| 03/16/2011 | CN101559038B Solid lipid nanoparticles of finasteride and preparation method thereof |
| 03/16/2011 | CN101530515B Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate |
| 03/16/2011 | CN101530490B Traditional Chinese medicine for treating bladder cancer |
| 03/16/2011 | CN101249231B Medicine composition for treating lithiasis and preparation thereof |
| 03/16/2011 | CN101167863B Proprietary Chinese medicine for treating diabetes and nephrosis and preparing method thereof |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | US7906141 Sustained-release, oral pharmaceutical forms of formulation |
| 03/15/2011 | CA2619042C Methods and compositions for the prevention and treatment of kidney disease |
| 03/15/2011 | CA2514114C Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 03/15/2011 | CA2496780C Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 03/15/2011 | CA2470703C Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 03/15/2011 | CA2430332C Use of 1-phenyl-3-dimethylaminopropane compounds for the treatment of urinary incontinence |
| 03/15/2011 | CA2426440C Quinazoline derivatives as kinase inhibitors |
| 03/15/2011 | CA2415611C Biologically active macrolides, compositions, and uses thereof |
| 03/15/2011 | CA2406064C Minimizing adverse experience associated with oxybutynin therapy |
| 03/15/2011 | CA2338982C Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 03/15/2011 | CA2277192C Nuclear transfer with differentiated fetal and adult donor cells |
| 03/15/2011 | CA2232191C Inhibition of tumor necrosis factor alpha |
| 03/10/2011 | WO2011029005A1 Crystalline forms of fesoterodine fumarate and fesoterodine base |
| 03/10/2011 | WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof |
| 03/10/2011 | WO2011027807A1 Immunity inducer |
| 03/10/2011 | WO2011026891A1 Substituted pyridine derivatives and their medical use |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060130 Neutralizing human anti-igfr antibody |
| 03/10/2011 | US20110060041 Method of reversing, preventing, delaying or stabilizing soft tissue calcification |
| 03/10/2011 | US20110059999 Hydroxymethylcyclohexylamines |
| 03/10/2011 | US20110059995 Substituted xanthine derivatives |
| 03/10/2011 | US20110059945 S1P Receptor Modulating Compounds and Use Thereof |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059927 Calcium Formate For Use As A Dietary Supplement |
| 03/10/2011 | US20110059923 Novel phosphate or a pharmaceutically acceptable salt thereof, a production method therefor and a pharmaceutical composition for preventing and treating central nervous system disorders containing the same as an active component |
| 03/10/2011 | US20110059896 Use of furin convertase inhibitors in the treatment of fibrosis and scarring |
| 03/10/2011 | US20110059885 Treatment of diseases and conditions mediated by eicosanoids |
| 03/10/2011 | US20110059152 Augmentation of organ function |
| 03/10/2011 | US20110059102 Therapeutic Method Targeting Midkine |
| 03/10/2011 | US20110059052 Cellular therapeutic agent for incontinence or urine comprising stem cells originated from decidua or adipose |
| 03/10/2011 | CA2773083A1 Immunity-inducing agent |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292622A1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/09/2011 | EP2292614A1 Substituted pyrimidines as aurora kinase inhibitors |
| 03/09/2011 | EP2292611A1 Novel thiophenediamine derivative having urea structure |
| 03/09/2011 | EP2292595A1 Potassium channel modulators |
| 03/09/2011 | EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II |
| 03/09/2011 | EP2291515A2 Methods for propagation of renal precursor cells |
| 03/09/2011 | EP2291403A1 Treatment of chronic prostatitis |
| 03/09/2011 | EP1559427B1 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 03/09/2011 | CN101984314A Preparation method for dry extract of total saponins of rehmannia leaves |
| 03/09/2011 | CN101984035A Health wine and preparation method thereof |
| 03/09/2011 | CN101984034A Health-care wine |
| 03/09/2011 | CN101983968A Preparation method of sepia oligopeptide by enzymatic hydrolysis and application thereof |
| 03/09/2011 | CN101983715A Medicine for rapidly curing prostatic hyperplasia and preparation method thereof |
| 03/09/2011 | CN101983699A Traditional Chinese medicine composition for treating kidney disease and preparation method thereof |
| 03/09/2011 | CN101983689A Drug for treating prostatitis and preparation method thereof |